SCHEMBL4555519

SCHEMBL4555519

O=C(O)N1CCc2c[nH]c3cccc(c23)C1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 2/20 0.48
GABRG2 P18507 2/20 0.48
GABRB3 P28472 2/20 0.48
GABRA3 P34903 2/20 0.48
GABRA2 P47869 2/20 0.48
GABRB2 P47870 2/20 0.48
DRD2 P14416 2/20 0.48
DRD1 P21728 2/20 0.48
DRD5 P21918 2/20 0.48
DRD4 P21917 1/20 0.48
DRD3 P35462 1/20 0.48
NOTUM Q6P988 1/20 0.42
MAPT P10636 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
TAAR1 Q96RJ0 1/20 0.41
MAOA P21397 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
NPC1 O15118 1/20 0.40
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL741883 0.81 ESR2 (0.53) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL11872266 0.78 NOTUM (0.56) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL741195 0.76 PARP1 (0.41) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL16353839 0.76 ESR2 (0.53) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL322928 0.74 NOTUM (0.70) NOTUMMAPTMEN1KMT2ATAAR1
Hydrochloric Acid SCHEMBL21496871 0.73 NOTUM (0.68) NOTUMMAPTMEN1KMT2ATAAR1
SCHEMBL10541250 0.72 DRD2 (0.52) DRD2DRD1DRD5DRD4DRD3
SCHEMBL11869205 0.72 GABRA1 (0.42) GABRA1GABRG2GABRB3GABRA3GABRA2
Hydrochloric Acid SCHEMBL28278641 0.72 NOTUM (0.66) NOTUMMAPTMEN1KMT2ATAAR1
SCHEMBL11869851 0.71 TMEM97 (0.47) GABRA1GABRG2GABRB3GABRA3GABRA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2134714-A1 TRICYCLIC ISOQUINOLINE DERIVATIVES FOR TREATMENT OF OBESITY Biovitrum AB (publ) (SE) 2009-12-23 EP disclosed
WO-2008110598-A1 TRICYCLIC ISOQUINOLINE DERIVATIVES FOR TREATMENT OF OBESITY BIOVITRUM AB (PUBL) (SE) 2008-09-18 WO disclosed